A rendering of Resilience's biomanufacturing site in Marlborough, MA that has been purchased by Oxford Properties Group (CNW Group/Oxford Properties Group Inc.)
February 17, 2023 03:21 PM EST
Deals
Pharma
Manufacturing

Ox­ford Prop­er­ties Group pur­chas­es Re­silience man­u­fac­tur­ing site for $125M

Tyler Patchen

News Reporter

The in­ter­na­tion­al re­al es­tate com­pa­ny Ox­ford Prop­er­ties Group has pur­chased a man­u­fac­tur­ing fa­cil­i­ty in the Boston sub­urbs.

Ac­cord­ing to Ox­ford, it has pur­chased a 120 …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

NewAms­ter­dam aces Phase 3 tri­al, but in­vestors are skep­ti­cal

Post-Hoc: RFK vs. Vivek, and the fu­ture of US drug pol­i­cy

FDA up­dates la­bel of 33-year-old can­cer drug with new dose and warn­ing

When gen­er­a­tive AI meets the FDA: First dig­i­tal health ad­comm kicks off dis­cus­sion

Pfiz­er part­ners with two more Flag­ship biotechs on obe­si­ty, can­cer

sponsored

Are pro­grams with com­pound­ed GLP-1s safe for your pop­u­la­tion?

A service from the Financial Times